Inmode Ltd Equity-NMS: INMD

Healthcare

Medical Devices

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$34.11

52W high :

$41.84

1Y :

38.41%

5Y :

127.06%

EPS(TTM): :

Shares O/S :

83.07 M

Market cap :

2.82 B

What is the share price of Inmode Ltd today?

Inmode Ltd (INMD) share price as of June 9, 2023, is $33.98. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Inmode Ltd?

Yes, Indian Investors can invest in the Inmode Ltd (INMD) Share by opening an international trading account with Angel One.

How can I purchase Inmode Ltd shares in India?

Purchasing Inmode Ltd (INMD) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Inmode Ltd (INMD) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Inmode Ltd?

Yes, you can purchase fractional shares of Inmode Ltd (INMD) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Inmode Ltd?

The market capitalization of Inmode Ltd on June 9, 2023, is $2.82 B.

In which sector Inmode Ltd belongs?

Inmode Ltd operates in the Healthcare sector, specifically in the Medical Devices industry.

What documents are required to invest in Inmode Ltd stocks?

In order to invest in Inmode Ltd (INMD) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.